Recent Insider Transactions - Ligand Pharmaceuticals (NASDAQ: LGND)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ LGND Ligand Pharmaceuticals

Sabba Stephen L / director

04/01/2025

Buy

$52.30

2,406

$126K

32,584

NASDAQ LGND Ligand Pharmaceuticals

Sabba Stephen L / director

04/01/2025

Sell

$52.30

2,406

$126K

NASDAQ LGND Ligand Pharmaceuticals

Reardon Andrew / officer: CLO & Secretary

03/04/2025

Buy

$115.26

28,043

$3.232M

28,043

NASDAQ LGND Ligand Pharmaceuticals

Espinoza Octavio / officer: Chief Financial Officer

03/04/2025

Buy

$115.26

32,717

$3.771M

32,717

NASDAQ LGND Ligand Pharmaceuticals

Espinoza Octavio / officer: Chief Financial Officer

03/04/2025

Sell

$115.03

5,000

$575K

18,879

NASDAQ LGND Ligand Pharmaceuticals

Davis Todd C / director, officer: Chief Executive Officer

03/04/2025

Buy

$115.26

93,476

$10.774M

93,476